TY - JOUR
T1 - Chinese herbal medicine for constipation
T2 - Zheng-based associations among herbs, formulae, proprietary medicines, and herb-drug interactions
AU - Zhong, Lidan
AU - Zheng, Guang
AU - Ge, Li
AU - Lin, Cheng Yuan
AU - Huang, Tao
AU - Zhao, Ling
AU - Lu, Cheng
AU - Lyu, Aiping
AU - Bian, Zhaoxiang
N1 - Funding Information:
We thank Health and Health Services Research Fund (Project No. 09101501), Hong Kong SAR, and Natural Science Foundation of China Project (NSFC-81173363) for financially support this research. The funding agencies have no role in the design and execution of this project. They will not be involved to the analysis and interpretation of data, or make decision to submit the results.
PY - 2016/6/23
Y1 - 2016/6/23
N2 - Background: As current symptomatic treatments of constipation are still unsatisfactory, an increasing number of patients seek help from Chinese medicine (CM), particularly Chinese herbal medicine (CHM). This study aimed to review the most frequently used CHM herbs and formulae, proprietary CHMs, and herb-drug interactions for functional constipation using zheng (syndrome)-based differentiation, and to determine the current practice of zheng-based CHM treatments for functional constipation. Methods: We developed a search strategy to include all the related clinical studies of CHM for constipation and set inclusion and exclusion criteria as studies on subjects with constipation of all ages and both sexes, using objective measures from laboratory or imaging techniques. The interventions included single herbs, CM classical formulae, CM new formulae, and Chinese herb-derived products and combination products. The clinical study types included were quasi- or randomized controlled trials, observational clinical studies, case series or case reports, and other types of appropriate research methods. The data concerning study design, sample size, mode of recruitment, sampling and diagnostic procedure, inclusion and exclusion criteria, and participants' characteristics (including age, sex, and duration of constipation). CM patterns, CM treatment principles, treatment regimen, and CM treatment outcomes were recorded. Results: A total of 29,832 relevant records were found, of which 8541 were duplicate records and 20,639 were excluded for reasons of irrelevance. The full text of 965 articles was retrieved for detailed assessment, following which 480 articles were excluded for various reasons. From the included articles, we retrieved 190 different CM zheng diagnoses from 485 individual studies. The most common zheng was dual deficiency of qi and blood (N=48), which was diagnosed in 948 out of 15,740 subjects. The most frequently used classical formula was Ma-Zi-Ren-Wan (MZRW) (N=75) and the most frequently used proprietary CHM was Run-Chang-Wan (N=87). The most frequently used combined medication was Da Huang with sodium bicarbonate tablets (frequency across all studies, n=23), followed by Fan Xie Ye with lactulose oral solution (n=8), Ma-Ren-Ruan-Jiao-Nang with lactulose oral solution (n=6) and Liu-Wei-An-Xiao-Jiao-Nang (n=6) with mosapride citrate tablets. Conclusion: This study examined the use of CHM for constipation and summarized the herbs, formulae, proprietary medicines, and herb-drug interactions application. These data indicated there were limited information about herb-drug interactions and adverse effects of CHM and further randomized controlled trials with strict design are necessary.
AB - Background: As current symptomatic treatments of constipation are still unsatisfactory, an increasing number of patients seek help from Chinese medicine (CM), particularly Chinese herbal medicine (CHM). This study aimed to review the most frequently used CHM herbs and formulae, proprietary CHMs, and herb-drug interactions for functional constipation using zheng (syndrome)-based differentiation, and to determine the current practice of zheng-based CHM treatments for functional constipation. Methods: We developed a search strategy to include all the related clinical studies of CHM for constipation and set inclusion and exclusion criteria as studies on subjects with constipation of all ages and both sexes, using objective measures from laboratory or imaging techniques. The interventions included single herbs, CM classical formulae, CM new formulae, and Chinese herb-derived products and combination products. The clinical study types included were quasi- or randomized controlled trials, observational clinical studies, case series or case reports, and other types of appropriate research methods. The data concerning study design, sample size, mode of recruitment, sampling and diagnostic procedure, inclusion and exclusion criteria, and participants' characteristics (including age, sex, and duration of constipation). CM patterns, CM treatment principles, treatment regimen, and CM treatment outcomes were recorded. Results: A total of 29,832 relevant records were found, of which 8541 were duplicate records and 20,639 were excluded for reasons of irrelevance. The full text of 965 articles was retrieved for detailed assessment, following which 480 articles were excluded for various reasons. From the included articles, we retrieved 190 different CM zheng diagnoses from 485 individual studies. The most common zheng was dual deficiency of qi and blood (N=48), which was diagnosed in 948 out of 15,740 subjects. The most frequently used classical formula was Ma-Zi-Ren-Wan (MZRW) (N=75) and the most frequently used proprietary CHM was Run-Chang-Wan (N=87). The most frequently used combined medication was Da Huang with sodium bicarbonate tablets (frequency across all studies, n=23), followed by Fan Xie Ye with lactulose oral solution (n=8), Ma-Ren-Ruan-Jiao-Nang with lactulose oral solution (n=6) and Liu-Wei-An-Xiao-Jiao-Nang (n=6) with mosapride citrate tablets. Conclusion: This study examined the use of CHM for constipation and summarized the herbs, formulae, proprietary medicines, and herb-drug interactions application. These data indicated there were limited information about herb-drug interactions and adverse effects of CHM and further randomized controlled trials with strict design are necessary.
UR - http://www.scopus.com/inward/record.url?scp=84975733545&partnerID=8YFLogxK
U2 - 10.1186/s13020-016-0099-4
DO - 10.1186/s13020-016-0099-4
M3 - Review article
AN - SCOPUS:84975733545
SN - 1749-8546
VL - 11
JO - Chinese Medicine (United Kingdom)
JF - Chinese Medicine (United Kingdom)
IS - 1
M1 - 28
ER -